In a joint letter to FDA, the industry trade groups propose a framework for FDA to implement a New Dietary Ingredient (NDI) master file and urge clarification on the agency’s views in a final NDI guidance.
Figure 1: Schema of the process of submitting an NDI master file and a subsequent NDI notification
In a joint letter to Steve Tave, director, Office of Dietary Supplements Programs, Center for Food Safety and Applied Nutrition at U.S. Food and Drug Administration (FDA), the Consumer Healthcare Products Association (CHPA; Washington, D.C.), the Council for Responsible Nutrition (CRN; Washington, D.C.), and the United Natural Products Alliance (UNPA; Salt Lake City, UT) propose a framework for FDA to implement a New Dietary Ingredient (NDI) master file and urge clarification on the agency’s views in a final NDI guidance. The goal of the NDI master file is to protect intellectual property.
“Responsible companies in the dietary supplement industry invest in generating the necessary data to establish the safety of their ingredients,” states the letter. “A significant concern for these ingredient manufacturers is that they must compete on an uneven playing field with companies that fail to generate and submit safety data specific to their NDIs and claim that their ingredients are identical to NDIs that other firms properly notified.”
Unfortunately, it is often not the case that ingredients are identical to existing NDIs, sometimes posing a safety risk to consumers. According to the letter, the lack of deterrence for unscrupulous companies bypassing the notification requirements only frustrates and discourages responsible companies from the NDI notification process, potentially stifling innovation. The NDI master file would be a tool to streamline the collection and protection of data investments made by ingredient manufacturers.
The way it would work is that in advance of an NDI notification, a manufacturer would submit confidential information (trade secrets) on the NDI to FDA in an NDI master file. FDA would acknowledge receipt of the information and assign an NDI master file number. FDA would not, however, approve or disprove the submission of the master file. FDA would only review the master file information in the context of an NDI notification under 21 CFR 190.6. The NDI master file holder would then be able to authorize oneself or a third party to reference the master file in an NDI notification by issuing a Letter of Authorization (see figure 1).
The proposed framework is modelled after the U.S. Drug Master File, which has been accepted by FDA for decades. It was developed by the members of CRN’s Master File Working Group, and has been reviewed by CHPA and UNPA.
“As partners in this industry effort, we jointly submit the proposed framework to encourage and assist FDA in implementing an NDI-MF system that will serve both the industry and the agency,” concludes the letter. “We underscore, however, that the utility, and ultimate success, of the NDI-master file will depend largely on FDA’s support and a strong commitment to enforcement of its proper use-establishing a master file program without the agency’s resolve and resources to enforce it, and to prosecute companies who ignore it, only perpetuates continued indifference and leaves the intellectual property of responsible and innovative companies unprotected.”
What's next for NPA and CRN in their complaints against New York state?
May 2nd 2024The latest updates in the efforts of the Natural Products Association and the Council for Responsible Nutrition to sue New York state for its law banning the sale of weight management and muscle building supplements to minors.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
U.S. Hemp Authority announces Adult Use Hemp Product Certification Program
April 15th 2024The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”